| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/22/2013 | CN102600092B Method for preparing sinomenine hydrochloride tablets by non-organic solvents |
| 05/22/2013 | CN102600088B Injection lansoprazole medicine composition and preparation method thereof |
| 05/22/2013 | CN102600085B Method for preparing sinomenine sustained-release injection by using inorganic solvent |
| 05/22/2013 | CN102579357B Magnet composite drug-carrying microspheres and preparation method thereof |
| 05/22/2013 | CN102579343B Method for improving target effect of receptor targeting preparation based on folic acid compounds |
| 05/22/2013 | CN102552925B Method for preparing alginic acid/attapulgite composite for sustained or controlled release tablets of medicine |
| 05/22/2013 | CN102552176B Austocystin D free-drying powder and preparation method thereof |
| 05/22/2013 | CN102525980B Children cetirizine hydrochloride composition |
| 05/22/2013 | CN102525941B Composite drug-loading sustained release microsphere system entrapped with quantum dots and preparation method of composite drug-loading sustained release microsphere system |
| 05/22/2013 | CN102397553B Method for improving drug release in carbon nano tube drug delivery system by displacement object |
| 05/22/2013 | CN102389401B Dexibuprofen particles and preparation method thereof |
| 05/22/2013 | CN102349872B Sulfuric acid cefquinome frozen powder injection and preparation method thereof |
| 05/22/2013 | CN102258475B Daidzein solid lipid nanoparticles and preparation method thereof |
| 05/22/2013 | CN102245211B Combined drug administration |
| 05/22/2013 | CN102228440B Method for preparing hydrophilic drug microsphere through spray drying process |
| 05/22/2013 | CN102199368B Carbon nanotube functional modification method through calcium phosphate in-situ deposition |
| 05/22/2013 | CN102198090B Pazufloxacin mesilate xylitol injection and preparation method thereof |
| 05/22/2013 | CN102170856B Hyaluronic acid-based gels including anesthetic agents |
| 05/22/2013 | CN102159192B Preparation method of biodegradable micro-particles containing drugs |
| 05/22/2013 | CN102125566B Pharmaceutical composition comprising cycloartenyl ferulate |
| 05/22/2013 | CN102119034B Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 05/22/2013 | CN101917967B Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 05/22/2013 | CN101897662B Ophtalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/22/2013 | CN101843614B Application of metronidazole or its pharmacologically acceptable derivative |
| 05/22/2013 | CN101766818B Polysaccharide gold-magnetic composite particle medicine carrier and preparation method thereof |
| 05/22/2013 | CN101721718B Lipid microbubble and preparation method thereof |
| 05/22/2013 | CN101623235B 干燥脂质体制剂 Dried liposomal formulation |
| 05/22/2013 | CN101010068B Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof |
| 05/22/2013 | CA2792574A1 Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, and method of production |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | US8445653 Freeze-dried preparation of stabilized anthracycline compound |
| 05/21/2013 | US8445647 Modified exendins and exendin agonists |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445612 Conjugation reactions |
| 05/21/2013 | US8445545 Pharmaceutical composition, method of preparation and methods of treating aches/pains |
| 05/21/2013 | US8445431 Ligands having metal binding ability and targeting properties |
| 05/21/2013 | US8445429 Lactoferrin and neuronal health and development in the infant gut |
| 05/21/2013 | US8445427 Endotoxin adsorbent, and method for removing endotoxin using the same |
| 05/21/2013 | US8445032 Melt-blended protein composition |
| 05/21/2013 | US8445014 Ion binding compositions |
| 05/21/2013 | US8445011 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| 05/21/2013 | US8444994 Multivalent antihelminthic vaccine |
| 05/21/2013 | US8444993 Multi-phase emulsions based on amphiphilic block copolymers |
| 05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
| 05/21/2013 | US8443799 Dry powder inhalation system for transpulmonary administration |
| 05/21/2013 | CA2809279A1 Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient |
| 05/21/2013 | CA2717276C Selenium containing modifying agents and conjugates |
| 05/21/2013 | CA2707766C Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 05/21/2013 | CA2583783C Complex containing mequitazine, a cyclodextrin and an interaction agent |
| 05/21/2013 | CA2572765C Compound having improved bioefficiency when administered in a multidose regimen |
| 05/21/2013 | CA2571292C Polymer-factor ix moiety conjugates |
| 05/21/2013 | CA2556993C Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides |
| 05/21/2013 | CA2509939C Thiol-selective water-soluble polymer derivatives |
| 05/21/2013 | CA2478011C Bispecific antibody point mutations for enhancing rate of clearance |
| 05/21/2013 | CA2459869C A system for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer |
| 05/21/2013 | CA2349203C Dispersible phospholipid stabilized microparticles |
| 05/21/2013 | CA2294865C Immunogenic lhrh compositions and methods relating thereto |
| 05/18/2013 | CA2793349A1 Novel drug delivery devices |
| 05/16/2013 | WO2013071235A1 In-situ cross-linkable polymeric compositions and methods thereof |
| 05/16/2013 | WO2013070856A1 Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract |
| 05/16/2013 | WO2013069897A1 Stabilised sustained-release preparation of sarpogrelate |
| 05/16/2013 | WO2013068949A1 Carrier molecule comprising a spr0096 and a spr2021 antigen |
| 05/16/2013 | WO2013068946A2 Antibodies specific for trop-2 and their uses |
| 05/16/2013 | WO2013068874A1 Antibody-drug conjugates |
| 05/16/2013 | WO2013068625A1 Nanoparticulate systems prepared from sorbitan esters |
| 05/16/2013 | WO2013068405A1 Composition for photodynamic diagnosis and treatment of tumors |
| 05/16/2013 | WO2013068117A1 Polymer aldehyde derivatives |
| 05/16/2013 | WO2013068014A1 Pharmaceutical compositions comprising lubricants for preventing or reducing aseptic loosening in a subject |
| 05/16/2013 | WO2013067769A1 Liquid composition of anti-hepatitis b virus |
| 05/16/2013 | WO2013067767A1 Polyethylene glycol-amino acid oligopeptide-irinotecan drug conjugate and drug composition thereof |
| 05/16/2013 | WO2013067597A1 Immunomodulatory conjugates |
| 05/16/2013 | WO2013033400A9 Methods for effectively and rapidly desensitizing allergic patients |
| 05/16/2013 | WO2012136790A9 Compositions comprising fusion proteins or conjugates with an improved serum half-life |
| 05/16/2013 | US20130123487 Controlled release from solid supports |
| 05/16/2013 | US20130123461 Controlled drug release from dendrimers |
| 05/16/2013 | US20130123375 Organogel Compositions Comprising Alkylated Benzimidazolones |
| 05/16/2013 | US20130123374 Process for modifying the properties of citrus pulp |
| 05/16/2013 | US20130123373 Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients |
| 05/16/2013 | US20130123338 Novel cationic lipids and methods of use thereof |
| 05/16/2013 | US20130123210 Dermal filler compositions including antioxidants |
| 05/16/2013 | US20130123199 Protein complex for intracellular delivery and uses thereof |
| 05/16/2013 | US20130123180 Fast dissolving pharmaceutical composition |
| 05/16/2013 | US20130123175 Compounds for Delivery of Therapeutic And Imaging Moieties to Nerve Cells |
| 05/16/2013 | US20130123108 Active substance composition comprising at least one nitrogen atom-containing, hyperbranched polymer |
| 05/16/2013 | US20130122526 Method of preparing a fusion protein for the inhibition or reduction of secretion of an extracellular mediator from a target cell |
| 05/16/2013 | US20130122295 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 05/16/2013 | US20130122112 Derivatized Hyperbranched Polyglycerols |
| 05/16/2013 | US20130122104 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 05/16/2013 | US20130122101 Abuse resistant drug formulation |
| 05/16/2013 | US20130122093 Formulations of a src/abl inhibitor |
| 05/16/2013 | US20130122078 Collagen-containing cell carrier |
| 05/16/2013 | US20130122064 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration |
| 05/16/2013 | US20130122056 Ratiometric Combinatorial Drug Delivery |
| 05/16/2013 | US20130122055 Anionic Charge-Dynamic Polymers for Release of Cationic Agents |
| 05/16/2013 | US20130122054 Lipid membrane structure having intranuclear migrating property |
| 05/16/2013 | US20130122023 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity |
| 05/16/2013 | US20130121990 Pharmaceutical formulations |
| 05/16/2013 | US20130121987 Therapeutic composition with a botulinum neurotoxin |
| 05/16/2013 | US20130121970 Method for elimination of space through tissue approximation |
| 05/16/2013 | US20130121954 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery |